JP4904498B2 - Rar活性化を起こす天然化合物 - Google Patents
Rar活性化を起こす天然化合物 Download PDFInfo
- Publication number
- JP4904498B2 JP4904498B2 JP2006511413A JP2006511413A JP4904498B2 JP 4904498 B2 JP4904498 B2 JP 4904498B2 JP 2006511413 A JP2006511413 A JP 2006511413A JP 2006511413 A JP2006511413 A JP 2006511413A JP 4904498 B2 JP4904498 B2 JP 4904498B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- rar
- group
- natural compounds
- retinoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
RAR結合配列(RARE)下にCMV promoterの3'側201 bpとenhanced yellow fluorescent protein (EYFP)遺伝子をつないだプラスミド(レポータープラスミド)とSV40 promoter下にenhanced cyan fluorescent protein (ECFP)遺伝子をつないだプラスミド(内部標準測定用プラスミド)、核内受容体発現用プラスミドとしてRXR遺伝子を有するプラスミド及びRAR遺伝子を有するプラスミドの4種をCOS7細胞に導入した。なお、RARそれぞれのサブタイプに対する活性化能の差を確認するためにRARとしてはRARα、RARβ、RARγそれぞれのサブタイプを発現するプラスミドを用意した。
Claims (3)
- 下記の式(3)又は(4)の化合物を有効成分として含有するレチノイド作用剤。
- 下記の式(2)〜(4)のいずれかの化合物を有効成分として含有する、ビタミンA欠乏症、又は骨疾患の予防・治療のための医薬剤。
- 下記の式(2)〜(4)のいずれかの化合物を有効成分として含有する、上皮組織の角化症、又は乾癬の予防・治療のための医薬剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006511413A JP4904498B2 (ja) | 2004-03-29 | 2005-03-03 | Rar活性化を起こす天然化合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004094321 | 2004-03-29 | ||
JP2004094321 | 2004-03-29 | ||
JP2006511413A JP4904498B2 (ja) | 2004-03-29 | 2005-03-03 | Rar活性化を起こす天然化合物 |
PCT/JP2005/003601 WO2005092322A1 (ja) | 2004-03-29 | 2005-03-03 | Rar活性化を起こす天然化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2005092322A1 JPWO2005092322A1 (ja) | 2008-02-07 |
JP4904498B2 true JP4904498B2 (ja) | 2012-03-28 |
Family
ID=35055968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006511413A Active JP4904498B2 (ja) | 2004-03-29 | 2005-03-03 | Rar活性化を起こす天然化合物 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4904498B2 (ja) |
WO (1) | WO2005092322A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5670070B2 (ja) * | 2010-03-04 | 2015-02-18 | ポーラ化成工業株式会社 | メラニン産生抑制剤 |
KR20220080108A (ko) * | 2019-09-17 | 2022-06-14 | 엔진 바이오사이언스 리미티드 | Src 키나제의 억제 그리고 연관된 장애의 치료 및 예방용 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610185A (en) * | 1995-02-17 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
CN1132577C (zh) * | 1996-09-05 | 2003-12-31 | 研究发展基金会 | 用咖啡酸苯乙酯抑制核转录因子NF-kB |
JP4738592B2 (ja) * | 1997-10-31 | 2011-08-03 | アーチ・デヴェロップメント・コーポレイション | 5α−還元酵素活性を調節するための方法及び組成物 |
-
2005
- 2005-03-03 JP JP2006511413A patent/JP4904498B2/ja active Active
- 2005-03-03 WO PCT/JP2005/003601 patent/WO2005092322A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JPWO2005092322A1 (ja) | 2008-02-07 |
WO2005092322A1 (ja) | 2005-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0991636B1 (en) | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities | |
US7265154B2 (en) | Valproic acid and derivatives thereof as histone deacetylase inhibitors | |
JP4691619B2 (ja) | アルコキシ基を有するレキシノイド化合物 | |
ES2216062T3 (es) | Tratamiento de la niddm con agonistas del rxr. | |
Nagpal et al. | Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi’s sarcoma | |
DE69720745T2 (de) | Therapeutische kombinationen von rar-antagonisten und rxr-agonisten | |
US20070238791A1 (en) | Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators | |
WO2002013812A1 (en) | Methods for treating inflammatory diseases | |
JP7163288B2 (ja) | 視細胞変性を伴う網膜変性疾患用薬 | |
SG176247A1 (en) | Lxr modulators | |
US10813905B2 (en) | Methods of treating sickle cell disease and related disorders using fumaric acid esters | |
JP2014076953A (ja) | レチノイドx受容体パーシャルアゴニスト化合物及びこのレチノイドx受容体パーシャルアゴニスト化合物を有効成分として含有する薬剤 | |
JPH10338658A (ja) | レチノイド作用調節剤 | |
EP1180520B1 (en) | Pyrimidine carboxylic acid derivatives | |
JP4904498B2 (ja) | Rar活性化を起こす天然化合物 | |
US20080139842A1 (en) | Medicament for preventive and/or therapeutic treatment of diseases with secretory disorder | |
JP5885140B2 (ja) | Rxrパーシャルアゴニスト | |
US6713515B2 (en) | Retinoic acid receptor antagonists as promoters of angiogenesis | |
JPH10114757A (ja) | レチノイドアンタゴニスト | |
US20040122080A1 (en) | Synergist combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
EP0879223B1 (fr) | Derives polycycliques aromatiques de type retinoide, leur procede de preparation et leur utilisation pour la fabrication de compositions pharmaceutiques et cosmetiques | |
JP2004528316A (ja) | 癌治療のための、レチノイド受容体リガンドおよび選択される細胞毒性剤の相乗的な組み合わせ | |
JPWO2010098125A1 (ja) | レチノイドx受容体パーシャルアゴニスト化合物 | |
JP3824422B2 (ja) | レチノイン酸の活性増強剤 | |
JP2021024826A (ja) | 糖化産物生成抑制剤及び医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110531 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110729 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110823 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111017 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111108 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111205 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4904498 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |